Response Biomedical Corp.
Manufactures on-site diagnotic tests and readers for use in hospital emergency rooms, as well as in infectious disease, biodefence and environmental arenas.
|Founded: 1992||Chief Executive(s): Jeffrey Purvin||Stock Ticker: TSX: RBM|
|Website: www.responsebio.com||Head Office: Vancouver|
|Growth 2007-12 (%): 230||Revenue 2012: 11,750,197||Reporting $: CAD|
|Exports as % of Sales: 100||Employees 2012: 73||Employees 2007: 99|